# Severe Nausea

**Policy Number:** 7304  
**Approved:** Bryan Cleaver, EMS Administrator  
Mark Luoto, EMS Medical Director  
**Effective Date:** January 1, 2020  
**Review Date:** May 25, 2021  
**Authority:** California Health and Safety Code, Division 2.5 EMS, Sections 1797.220 & 1797.221

## I. Definition

A. Nausea or persistent vomiting.

B. Motion sickness.

## II. Basic Life Support

A. Provide General Medical Care

## III. Advance Life Support

### Adult

**A. Consider NS fluid bolus 250 ml IV for volume depletion if patient has been experiencing significant vomiting.**

1. May repeat if indicated.

**B. Administer Ondansetron 4 mg slow IVP/IM/PO.**

1. May repeat initial dose every 10 minutes if symptoms persist.
2. Max dose 12 mg.

**C. If patient is pregnant consider Diphenhydramine 25 mg â€“ 50 mg IV/IM.**

**D. For motion sickness:**

1. Administer Diphenhydramine 25 mg - 50 mg Slow IVP/IM.
   a. Max dose 50 mg.
   b. For patients over 65 years of age administer 12.5 mg Slow IVP (over 1 to 2 minutes) or IM. May repeat once.

### Pediatric (less than 14 years of age)

**A. Consider NS fluid bolus 20 ml/kg IV for volume depletion if patient has been experiencing significant vomiting.**

1. Do not repeat.

**B. For patients age 4 and older, refer to adult treatment.**

**C. For motion sickness:**

1. Administer Diphenhydramine per pediatric medication administration guide.
   a. Do not repeat.

## IV. Special Considerations

A. Ondansetron may be co-administered with narcotics when administered for pain control.

B. Administer Diphenhydramine with caution in patients over 65 years of age. Diphenhydramine may cause delirium or exacerbation of neurocognitive disorders such as dementia.

## V. Base Orders

A. Additional Ondansetron administration beyond max dose requires Base Hospital consult and approval.

## VI. Contraindications

A. Ondansetron administration is contraindicated in pregnancy.

## VII. Cross Reference

A. General Medical Care Policy No. 7001
B. Severe Pain Policy No. 7305

